WATSON 582 (Propafenone 150 mg)
Pill imprint WATSON 582 has been identified as Propafenone hydrochloride 150 mg.
Propafenone is used in the treatment of atrial fibrillation; ventricular tachycardia; wolff-parkinson-white syndrome; atrial flutter and belongs to the drug class group I antiarrhythmics. Risk cannot be ruled out during pregnancy. Propafenone 150 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for WATSON 582 (Propafenone 150 mg)
- 150 mg
- 9.00 mm
- Prescription only
- Drug Class:
- Group I antiarrhythmics
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Watson Laboratories, Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- silicon dioxide
sodium lauryl sulfate
|NDC Code||Manufacturer / Repackager|
|68084-0361||Amerisource Health Services|
|54868-4770||Physicians Total Care Inc (repackager)|
Note: Inactive ingredients may vary.
Propafenone hydrochloride is associated with the treatment of:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...